GigaDevice Anchors Global Headquarters in Singapore to Power Synergy and Impact
GigaDevice, a leading semiconductor company specializing in Flash memory, 32-bit microcontrollers (MCUs), sensors, and analog products, today officially opened its global headquarters in Singapore. This strategic move marks a major milestone in GigaDevice’s international growth journey, underscoring its commitment to closer customer engagement, building a resilient and agile supply chain, and strengthening its ecosystem and brand presence across key global markets.
Founded in 2005, GigaDevice has rapidly built a competitive product portfolio and innovative solutions. Its SPI NOR Flash commands the No. 2 global position with a 20.4% market share, and it ranks No. 7 worldwide in the 32-bit general-purpose MCU segment. Serving diverse sectors including industrial, automotive, consumer, and IoT, GigaDevice is recognized for delivering semiconductor solutions with reliability and innovation at its core.
As global demand for smart, connected technologies accelerates—particularly in industrial automation, automotive electronics, and intelligent edge devices—GigaDevice is sharpening its focus on innovation, supply chain agility, and ecosystem collaboration. The company is positioning itself to meet the evolving needs of international customers and capture opportunities across fast-growing markets.
“We chose Singapore not just for its strategic location, but for its clarity, consistency, and global ambition,” said Jennifer Zhao, GigaDevice Global Business CEO. “This is more than a regional office—it’s a collaborative innovation hub where expertise across disciplines and borders comes together to build smarter systems, accelerate execution, and power what’s next.”
Singapore’s robust infrastructure, pro-innovation environment, and exceptional talent pool have established it as a global premier technology and business hub. Its strong connectivity, transparent regulatory framework, and dedication to digital transformation provide the ideal foundation for companies like GigaDevice to scale globally while maintaining agility and future readiness.
Functioning alongside GigaDevice’s group headquarters in China, the Singapore global headquarters will serve as a central platform to drive global coordination, foster localized product innovation, and deepen collaboration with customers and supply chain partners. From this base, the company aims to expand its presence in international markets and build a more connected, agile, and responsive global ecosystem.
*GigaDevice and their logos are trademarks, or registered trademarks of GigaDevice Semiconductor Inc. Other names and brands are the property of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250603700345/en/
Contacts
Phone number: + 86 (010) 8288 1196
Email address: marcom@gigadevice.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
New Partnership Between Onboard Dynamics and T.D. Williamson Aims to Reduce Pipeline Emissions Across Eastern Hemisphere5.6.2025 08:00:00 EEST | Press release
Onboard Dynamics LLC (“Onboard Dynamics”), a leading developer of pipeline evacuation technology, has entered into a strategic partnership with T.D. Williamson (“TDW”), a global provider of pipeline services and equipment. This collaboration will enable TDW to represent, market, and sell Onboard Dynamics’ products and services directly to customers across the Eastern Hemisphere through its own network of channel partners. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250604551886/en/ Onboard Dynamics’ GoVAC® Pipeline Evacuation System—an innovative, self-powered mobile unit designed to capture and recover natural gas during pipeline evacuations, eliminating the need for venting or flaring. Pictured here in action during a pipeline drawdown project in France. The partnership spans a broad and strategically important region—including Europe, Central Asia, the Middle East, Africa, India, and the Asia-Pacific—where the demand f
Special Seminar Paves the Way for European Dairy Brands to Enter China ’ s Special Food Market Under New Rules5.6.2025 05:50:00 EEST | Press release
CCIC Europe Food Test Co., Ltd. (CCIC EFT) is stepping up efforts to help more European companies access China’s infant formula market. On June 25–26, CCIC EFT will host a targeted seminar in Wageningen, the Netherlands, focused on regulatory updates and market access for producers of infant formula, older infant and toddler milk-based formula, and food for special medical purposes (FSMP). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250604444992/en/ CCIC Europe Food Test Co., Ltd. (CCIC EFT) and Technology Innovation Center of Special Food, State Administration of Market Regulation (TISF, SAMR) in the Netherlands. Co-organized with the Technology Innovation Center of Special Food, State Administration of Market Regulation (TISF, SAMR), the seminar is designed for professionals familiar with Chinese regulations and seeking the latest updates on standards, product registration, and market trends. Attendees will benefit from
Belkin Unveils New Gaming Portfolio Featuring Power-Packed Charging Accessories and Gaming Essentials5.6.2025 02:00:00 EEST | Press release
Belkin, a leading consumer electronics brand for over 40 years, today announced its entry into the gaming accessories space with the launch of a new lineup designed to be compatible with the highly anticipated Nintendo Switch 2. Built on decades of experience in power, connectivity and device protection, and released under Belkin’s innovation-focused Future Ventures category, this marks the company’s first collection of products tailored specifically for the gaming community. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250604528148/en/ Belkin’s lineup of Nintendo Switch 2 accessories Belkin is “Leveling up your play” – bringing a new level of reliability to the gaming ecosystem that differentiates through premium materials, timeless design, and in-house engineering. The new range includes elevated accessories designed to enhance the Nintendo Switch 2 experience, featuring on-the-go charging solutions, audio gear, robust s
Biocytogen and Nanjing Chia Tai Tianqing Announce IND Approval in China for Co-Developed Anti-IGF-1R Antibody NTB003 (BCG009)5.6.2025 02:00:00 EEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, HKEX: 02315) and Nanjing Chia Tai Tianqing Pharmaceutical Co., Ltd. (“NJCTTQ”) announced that NTB003 (formerly BCG009), a co-developed injectable drug candidate, has received the Investigational New Drug (IND) approval from the National Medical Products Administration (NMPA). The approved indication is Thyroid Eye Disease (TED). About NTB003 Injection NTB003 is a second-generation fully human anti-IGF-1R monoclonal antibody co-developed by Biocytogen and Nanjing Chia Tai Tianqing. Antibody discovery and optimization were completed by Biocytogen using its proprietary RenMab™ fully human antibody discovery platform, while Nanjing Chia Tai Tianqing was responsible for CMC process development, GLP-compliant toxicology studies, and IND application. Compared with first-generation approved anti-IGF-1R therapeutics, NTB003 demonstrates enhanced molecular affinity, improved druggability, and an extended half-life. In vitro studies ha
New Potential Treatment Strategy for Brain Metastases and Leptomeningeal Disease: HER3-DXd Shows Promising Results in the Phase II TUXEDO-3 Study for Patients With Limited Therapeutic Options4.6.2025 21:19:00 EEST | Press release
Leading international medical research company, MEDSIR announced today the positive results of the TUXEDO-3 trial at the American Society of Clinical Oncology (ASCO) Annual Meeting 2025. This phase II study funded by Daiichi Sankyo and Merck, known as MSD outside of the United States and Canada, evaluates the efficacy and safety of patritumab deruxtecan (HER3-DXd) in patients with active brain metastases and leptomeningeal disease, serious complications associated with advanced stages of the cancer. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250604087994/en/ Dr. Matthias Preusser during Oral Presentation of TUXEDO-3 at ASCO 2025 The study was carried out to evaluate HER3-DXd in patients with metastatic breast cancer (mBC) and advanced non-small cell lung cancer (aNSCLC) with active brain metastases, and patients with leptomeningeal disease from solid tumors. This is an antibody-drug conjugate to target HER3, a protein re
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom